In patients with previously treated metastatic uveal melanoma, the historical 1 year overall survival rate is 37% with a median overall survival of 7.8 months. We conducted a …
ZJF Assaf, W Zou, AD Fine, MA Socinski, A Young… - Nature Medicine, 2023 - nature.com
One of the great challenges in therapeutic oncology is determining who might achieve survival benefits from a particular therapy. Studies on longitudinal circulating tumor DNA …
R Bruno, P Chanu, M Kågedal, F Mercier… - British journal of …, 2023 - nature.com
Longitudinal models of biomarkers such as tumour size dynamics capture treatment efficacy and predict treatment outcome (overall survival) of a variety of anticancer therapies …
Z Eslami-S, LE Cortés-Hernández, L Sinoquet… - British Journal of …, 2024 - nature.com
Abstract Background Circulating tumour cells (CTCs), circulating tumour DNA (ctDNA), and extracellular vesicles (EVs) are minimally invasive liquid biopsy biomarkers. This study …
Purpose: Androgen receptor pathway inhibitors (ARPI) are standard of care for treatment- naïve metastatic castration-resistant prostate cancer (mCRPC), but rapid resistance is …
M Laurie, J Lu - npj Systems Biology and Applications, 2023 - nature.com
While tumor dynamic modeling has been widely applied to support the development of oncology drugs, there remains a need to increase predictivity, enable personalized therapy …
Purpose: We sought to identify features of patients with advanced non–small cell lung cancer (NSCLC) who achieve long-term response (LTR) to immune checkpoint inhibitors …
PC Mack, J Miao, MW Redman, J Moon… - Clinical Cancer …, 2022 - AACR
Purpose: Dynamic changes in circulating tumor DNA (ctDNA) are under investigation as an early indicator of treatment outcome. Experimental Design: Serial plasma ctDNA (baseline, 8 …
Liquid biopsies have emerged as a promising tool for the detection of metastases as well as local and regional recurrence in lung cancer. Liquid biopsy tests involve analyzing a …